Pfizer Alzheimer’s drug fails in study (USA Today)

A promising Alzheimer’s disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment after the potential blockbuster kept symptoms from worsening for a year in a prior test.

Link:
Pfizer Alzheimer’s drug fails in study (USA Today)

Tags: partner-are, prior-test-, late-stage-study, a-prior-test-, a-partner-are, kept-symptoms, potential-blockbuster

Related posts:

  1. Pfizer Alzheimer’s disease drug fails in study (AP via Yahoo! News)
  2. Drug fails in one BU Alzheimer study, hormone link seen in other
  3. Mystery Alzheimer’s Drug May Yield Advance for Pfizer (Update1) (Bloomberg)
  4. Adeona Zinc Tab Fails to Aid Alzheimer’s Patients
  5. Mystery Medicine for Alzheimer’s May Yield Advance for Pfizer (BusinessWeek)

This entry was posted on Thursday, March 4th, 2010 at 11:32 am and is filed under Alzheimer's Disease. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply